Travere Therapeutics, Inc. Common Stock TVTX
$56.93
+0.14%
at last close
Recent SEC Filings
| Form | Description | Filed | Document |
|---|---|---|---|
| 8-K | 8-K | 2026-09-21 | View → |
| 4 | Insider transaction | 2026-09-17 | View → |
| 4 | Insider transaction | 2026-09-17 | View → |
| 4 | Insider transaction | 2026-09-17 | View → |
| 4 | Insider transaction | 2026-09-17 | View → |
| 4 | Insider transaction | 2026-09-17 | View → |
| 4 | Insider transaction | 2026-09-17 | View → |
| 4 | Insider transaction | 2026-09-17 | View → |
| 4 | Insider transaction | 2026-09-11 | View → |
| 4 | Insider transaction | 2026-09-03 | View → |
| 4 | Insider transaction | 2026-08-19 | View → |
| 10-Q | 10-Q | 2026-08-04 | View → |
| 8-K | 8-K | 2026-08-04 | View → |
| 8-K | 8-K | 2026-07-09 | View → |
| 4 | Insider transaction | 2026-06-22 | View → |
| 4 | Insider transaction | 2026-06-16 | View → |
| 4 | Insider transaction | 2026-06-16 | View → |
| 8-K | 8-K | 2026-06-16 | View → |
| 8-K | 8-K | 2026-06-02 | View → |
| 4 | Insider transaction | 2026-05-21 | View → |
| 4 | Insider transaction | 2026-05-21 | View → |
| 4 | Insider transaction | 2026-05-21 | View → |
| 4 | Insider transaction | 2026-05-21 | View → |
| 4 | Insider transaction | 2026-05-21 | View → |
| 4 | Insider transaction | 2026-05-21 | View → |
| 4 | Insider transaction | 2026-05-21 | View → |
| 4 | Insider transaction | 2026-05-21 | View → |
| 4 | Insider transaction | 2026-05-21 | View → |
| 8-K | 8-K | 2026-05-21 | View → |
| 4 | Insider transaction | 2026-05-19 | View → |
| 8-K | 8-K | 2026-05-11 | View → |
| 424B5 | 424B5 | 2026-05-07 | View → |
| 4 | Insider transaction | 2026-05-06 | View → |
| 4 | Insider transaction | 2026-05-06 | View → |
| 4 | Insider transaction | 2026-05-06 | View → |
| 4 | Insider transaction | 2026-05-06 | View → |
| 4 | Insider transaction | 2026-05-06 | View → |
| 4 | Insider transaction | 2026-05-06 | View → |
| 4 | Insider transaction | 2026-05-06 | View → |
| 4 | Insider transaction | 2026-05-06 | View → |
Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.
Key Stats
- Last Close
- $56.93
- Market Cap
- $5.37 billion
- 52-Week Range
- $17.27 – $68.73
- Average Volume
- 1.51 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.